Redefining Asthma and Clinical Remission

In this webinar, Dr Rashad Salman a respiratory consultant presents on the points to consider when following the latest national BTS/NICE/SIGN guidance with clinical remission as the goal. Whilst going through the treatment algorithm, he highlights the dangers of steroid burden, importance of biomarker-led decisions, and what choices are available to our patients.  

Please also consider watching the on-demand video ‘Biomarker-Led Asthma Care‘ by Helena Cummings who discusses ways of putting this into clinical practice.  

We hope that you found the content valuable. To ensure that we continue to provide topics and content of interest, we would very much value your feedback by completing a short questionnaire.

• Dr Rashad Salman

  Respiratory Medicine Consultant

  Read biography
  Dr Rashad Salman

  Respiratory Medicine Consultant Leeds Teaching Hospitals Trust

  Role and Location
  Rashad has been working within the respiratory medicine specialty since 2015, and as a respiratory medicine consultant at Leeds Teaching Hospitals Trust since 2020

  Memberships
  Rashad helped establish the long COVID rehabilitation service in Leeds, which won the British medical team of the year in 2022 in innovative medicine.

  Research Interests
  Has a special interest in difficult asthma, sleep medicine, biologic therapy, airway diseases and long COVID rehabilitation. As well as treating general respiratory conditions, Rashad offers diagnostic procedures including bronchoscopy and endo-bronchial ultrasound. 

  He also has a special interest in clinical research, conducting clinical trials in order to help patients access novel therapies.

  Rashad has been author and co-author in multiple publications in the fields of airway diseases, long COVID and other respiratory conditions.